The detection of the IGH::CCND1 translocation in the 2023 bone marrow specimen raises questions about whether the patient developed a second lymphoma—mantle cell lymphoma (MCL) or this rearrangement is a manifestation of clonal evolution within CLL. Here, CCND1 is linked to mantle cell lymphoma.